Page last updated: 2024-10-24

chloroquine and Beckwith-Wiedemann Syndrome

chloroquine has been researched along with Beckwith-Wiedemann Syndrome in 1 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Beckwith-Wiedemann Syndrome: A syndrome of multiple defects characterized primarily by umbilical hernia (HERNIA, UMBILICAL); MACROGLOSSIA; and GIGANTISM; and secondarily by visceromegaly; HYPOGLYCEMIA; and ear abnormalities.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reece, M1
Prawitt, D1
Landers, J1
Kast, C1
Gros, P1
Housman, D1
Zabel, BU1
Pelletier, J1

Other Studies

1 other study available for chloroquine and Beckwith-Wiedemann Syndrome

ArticleYear
Functional characterization of ORCTL2--an organic cation transporter expressed in the renal proximal tubules.
    FEBS letters, 1998, Aug-21, Volume: 433, Issue:3

    Topics: Animals; Bacteria; Base Sequence; Beckwith-Wiedemann Syndrome; Biological Transport; Carrier Protein

1998